Skip to content

Antibiotic Prophylaxis in Adult Heart Transplantation: a French National Survey

Antibiotic Prophylaxis in Adult Heart Transplantation: a French National Survey

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02479503
Acronym
ATC
Enrollment
21
Registered
2015-06-24
Start date
2015-03-31
Completion date
2015-07-31
Last updated
2020-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Heart Transplantation, Antibiotic Prophylaxis

Keywords

antibiotic prophylaxis heart transplantation

Brief summary

The study focuses on the antibiotic prophylaxis use in adult heart transplantation in France.

Detailed description

In adult heart transplantation, clinical situations differ between patients (elective, emergency, redux surgery, ventricular assisting device or extracorporeal live saving). At investigator's knowledge, there is not recommendations in France about antibiotic prophylaxis in adult heart transplantation. So, investigators aimed to study the antibiotic prophylaxis use in adult heart transplantation in France. Investigators conduct a French national survey about antibiotic prophylaxis used in adult heart transplantation center. Clinical situations such as elective, emergency, redux surgery, ventricular assisting device or extracorporeal live saving are investigated. Study was performed after Institutional approval was obtained from the local Ethics Committee (Comite de Protection des Personnes Nord Ouest III). An electronic survey was sent to all French adult heart transplantation centers (22) on march 1st, 2015. Reminders were planned on week 2 and 4 after initial sending. On june 2015, nonresponding centers were contacted by phone. Data were collected by a single investigator.

Interventions

PROCEDUREAntibiotic prophylaxis in adult heart transplantation

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* All French centers performing adult heart transplantation in 2015

Exclusion criteria

* not responding center * no adult heart transplantation

Design outcomes

Primary

MeasureTime frame
Class of antibiotic used as prophylaxis in adult heart transplantationone year

Secondary

MeasureTime frameDescription
Class of antibiotic used as prophylaxis in adult heart transplantation in regard to clinical situationone yearelective, emergency, redux surgery, ventricular assisting device or extracorporeal live saving
Fungal prophylaxis in adult heart transplantationone year
Other prophylactic measures (isolation, specific room, family visits) used in adult heart transplantationone year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026